Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Daily monitoring turns awareness into savings. This intro highlights simple routines to track spending and reinforce smart choices.
20,684 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Active fund moves can shake even steady income plays. This article breaks down why cushing asset management sells Hes...
Opendoor stock popped today amid optimism about profitability progress and better unit economics. This article breaks...
If you’re hunting for a lifelong holding, the dividend track record of Medtronic is hard to ignore. This piece explai...
Analyzing octave specialty (osg) earnings calls goes beyond quarterly numbers. This guide breaks down the key metrics...
A standout earnings beat pushed Clear Secure stock higher on Wednesday as revenue, user growth, and guidance surprise...
WTRG just released its quarterly earnings, and the market is parsing revenue growth, margins, and forward guidance. T...
Markets shift from mega-cap tech to overlooked small firms. This story highlights three small-cap ETFs to buy before ...
A Wayfair co-founder recently sold a substantial stake, signaling a strategic portfolio reshuffle amid ambitious expa...
Viking Holdings (VIK) 2025 reveals how the company navigated a mixed year. This analysis breaks down Q4 results, marg...
Nebius Group stock charged higher on Wednesday amid fresh AI cloud developments. This article breaks down the catalys...
As stocks march unfolds, the electric vehicle sector presents both challenges and opportunities. Here are two underva...